34 Pages Posted: 26 Dec 2009 Last revised: 28 Nov 2014
Date Written: December 22, 2009
This paper compares and contrasts how innovation – the successful introduction of new products, services, or techniques – is occurring in biotechnology seeds in China and India. We begin with an overview of the agricultural challenges faced by China and India and the substantial investments that both countries are making in agricultural research and development (R&D) and biotechnology to address these challenges. We next describe each country’s approach to three supply-side factors identified by industry sources as important to innovation in biotech seeds: Market access, intellectual property (IP) protection, and regulatory review processes. We find substantial problems in all three areas including limited market access for foreign firms in China and significant price caps in India; limitations and gaps in IP protection and enforcement; and lengthy delays in regulatory review. We conclude with a case study highlighting how the three factors shaped the introduction and adoption of the first widely commercialized biotech crop in China and India, Bt cotton.
Keywords: biotechnology, seeds, China, India, intellectual property, market access, regulatory review
JEL Classification: F14, K33, L52, L66, N55, O13, 014, 033, 034, Q16
Suggested Citation: Suggested Citation
Linton, Katherine and Torsekar, Mihir, Innovation in Biotechnology Seeds: Public and Private Initiatives in India and China (December 22, 2009). Available at SSRN: https://ssrn.com/abstract=1527200 or http://dx.doi.org/10.2139/ssrn.1527200